Investor Relations & Capital Introduction Services in Italy

Italian startups raised approximately €1.735 billion across 436 funding rounds in 2025, an increase of around 18% on the previous year. It was Italy's second strongest year on record behind 2022, and if the largest transactions are excluded, the strongest ever. The final quarter alone delivered roughly €901 million against €316 million in the third, making it the best quarter Italy has recorded.

Alongside that growth sits a structural fact that shapes everything: Italy recorded no venture-backed initial public offerings in 2025, and just 31 merger and acquisition transactions. Over the past decade, only 22 Italian IPOs have involved venture-backed companies at all. Italy has built a functioning early and mid-stage investment market on top of an exit market that barely exists.

Global Capital Network provides investor relations and capital introduction services for companies raising in Italy, and for allocators seeking structured access to Italian dealflow. Where liquidity is the constraint rather than capital, the composition of a cap table and the identity of an eventual acquirer matter earlier than they would elsewhere.

Capital Raising & Investor Introductions in Italy

The stage distribution reveals where the pressure sits. Seed-stage investment gained ground during 2025, frequently at the expense of Series B and later rounds, and Series C and beyond declined outright. Late-stage funding is the clear bottleneck in the Italian ecosystem, and it connects directly to the exit problem: without visible liquidity, domestic growth capital struggles to form.

For founders, the practical consequence is that a company reaching Series B in Italy should assume its lead investor may need to be international, and should build those relationships well before the round. Waiting until the domestic market proves insufficient is a common and expensive mistake here.

Ten rounds exceeded €25 million during 2025, all of them concentrated in the second half of the year. Many of the larger transactions incorporated debt or secondary components rather than being straightforward equity rounds, which is itself a signal about how capital is being structured in the absence of conventional exits.

By deal count, smart city and urban technology led with 71 rounds, followed by software at 62, deep technology at 60, life sciences at 58, and financial technology at 43. By capital deployed the order shifts: software attracted approximately €494 million, life sciences around €417 million, and deep technology roughly €269 million. That divergence between volume and value is worth noting, since it indicates where large rounds are actually possible.

Nine new funds raised approximately €545 million during 2025, down from the previous year's record but still adding dry powder, with notable momentum among vertical-focused and first-time managers.

GCN supports Italian companies across seed, growth and later stages, with particular focus on the Series B transition where the domestic market thins.

Pitch Deck Design & Fundraising Preparation

Italian founders raising beyond seed are usually presenting to investors who will ask a question founders in larger markets rarely face directly: how does this end? With no IPO route and limited domestic M&A, an investor needs a credible account of eventual liquidity before they commit.

GCN works with founders on exactly that. Who the realistic acquirers are, whether they are Italian or international, what would make the company attractive to them, and what milestones move it closer. This is not a speculative exercise; it is increasingly the deciding factor in Italian growth rounds.

Preparation also has to address international legibility. Most Italian companies raising above €25 million will need investors outside Italy, and those allocators do not carry Italian market context. Domestic market size framed alone reads as limiting, and the European or global expansion case needs supporting evidence rather than assertion.

For life sciences and deep technology companies, which together represent a substantial share of Italian capital, preparation extends to clinical or technical pathway, regulatory strategy, and the capital required to reach commercial revenue. These are the categories where Italian research depth is genuine and where the largest rounds are being written.

Investor Events, Dinners & Networking in Italy

Italian venture activity concentrates heavily around Milan, with meaningful activity in Rome, Turin, Bologna and the university centres. Milan's dominance means a founder based elsewhere is generally better served by engaging there than by building locally.

GCN convenes private investor dinners and closed sessions matched by sector and stage, with mandates verified in advance. For companies approaching growth stage, we deliberately compose rooms that include international allocators, because that reflects where a larger Italian round realistically originates.

Our programming addresses where Italian capital is concentrated: software and enterprise technology, life sciences, deep technology, smart city and urban systems, and financial technology. Sessions are scheduled around the established Italian and European calendar so that visiting allocators can participate without arranging separate travel.

Investor Webinars & Digital Capital Access

Because Italian growth rounds frequently depend on international participation, digital access is structural rather than supplementary.

GCN runs online investor sessions connecting Italian founders with allocators across Europe, North America and beyond. These are structured for assessment rather than exposure, with short presentations, protected question time, and follow-up routed only to investors who signal genuine interest.

Hybrid formats pair a Milan gathering with remote attendance, extending reach to London, Paris, Munich, Zurich and New York. For life sciences and deep technology companies in particular, reaching specialist investors in established clusters matters more than general exposure.

Services for Investors in Italy

For allocators, Italy offers a market in genuine growth with valuations that have not experienced the inflation seen in larger European ecosystems. Deal volume rose in 2025 while Europe's overall deal count declined, and Italy's strongest quarter on record closed the year.

The exit constraint should be understood clearly rather than discovered later. With no venture-backed IPOs in 2025, 31 M&A transactions, and only 22 venture-backed IPOs across the past decade, liquidity in Italy depends on trade sale or secondary structures. Investors comfortable with those routes, and with longer holds, are appropriately positioned. Those underwriting to a public listing are not.

That constraint is also what creates the opportunity. Limited domestic growth capital means international allocators face materially less competition for Italian companies that have already proven their model, and entry terms reflect that.

GCN provides curated dealflow filtered against stated criteria rather than general distribution, and remains involved through diligence rather than stepping back at introduction.

GCN Deal Flow Platform & Investor Matching

Our platform organises Italian opportunities by sector, stage, geography and thesis. Stage filtering carries particular weight here: the companies most actively seeking international capital sit at an identifiable point in their development, and finding them is largely a filtering problem.

Matching operates on cheque size, stage preference, sector mandate and geographic scope, with attention to whether a company's realistic lead investor is domestic or international.

Why Italy Is Attractive for Investors

Growth is real and broadening. Investment rose approximately 18% to €1.735 billion in 2025 across 436 rounds, up from 405, making it Italy's second-best year on record and its best ever excluding the largest transactions.

Momentum is accelerating. The fourth quarter of 2025 delivered roughly €901 million against €316 million in the third, the strongest quarter Italy has recorded.

Research-heavy sectors are attracting the largest rounds. Software led by value at approximately €494 million, followed by life sciences at €417 million and deep technology at €269 million, reflecting genuine institutional depth rather than consumer software cycles.

Competition for growth-stage companies is limited. With late-stage funding identified as the ecosystem's primary bottleneck, allocators with growth capacity face substantially less competition than in comparable European markets.

Partner with Global Capital Network in Italy

For founders raising in Italy, GCN provides investor relations infrastructure connecting Italian companies with domestic and international capital, with particular focus on the growth stage where the domestic market thins. Our approach is relationship-led, and we judge our work by whether an introduction still matters two funding rounds later.

For investors seeking Italian exposure, we deliver curated dealflow, diligence support and relationship facilitation across the sectors where Italian companies are strongest. Whether you allocate as a fund, a family office, or a strategic acquirer, our role is to shorten the distance between your mandate and the companies that match it.

To discuss your objectives in Italy, whether you are based in Milan, Rome, Turin, Bologna, or engaging from international markets, our team is available to talk through how we can help.